Case Study: Launching a new molecule for a rare disease

By Innomar Strategies

The challenge
How do you launch a new rare disease infusion product in a country where you have never launched a product before?

A U.S.-based company with no prior experience in the Canadian market came to Innomar-Strategies with this challenge.

Enter your information below to download the case study.


By clicking this box, you are consenting to receive emails from Innomar Strategies such as news, industry updates, announcements, events, offers and other promotional materials. You may modify your subscription preferences or withdraw your consent anytime. You also confirm you have read, understand, and agree to the Innomar Strategies Terms and Conditions and the Privacy Policy.


 

If you have any questions, please contact us by writing to Innomar Strategies, 3470 Superior Court, Oakville, Ontario L6L 0C4, Canada or by calling us at (905) 847-4310.